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Several recent epidemiological studies have 
emphasized the possible role of environmental 
pollutants in obesity and the metabolic syn-
drome. The serum concentrations of persistent 
organic pollutants (POPs) such as polychlo-
rinated dibenzo-p-dioxins and dibenzo  furans 
(PCDD/Fs), polychlorinated biphenyls 
(PCBs), and organochlorine pesticides are 
reported to be associated with body mass 
index, elevated triglycerides, glucose intoler-
ance, and cardiovascular diseases (Airaksinen 
et al. 2011; Alonso-Magdalena et al. 2011; Ha 
et al. 2007; Uemura et al. 2009). Molecular 
and cellular mechanisms of 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD), the most 
potent compound of PCDD/Fs, are well 
characterized. TCDD was shown to induce 
xenobiotic-metabolizing enzymes as well as 
other genes involved in cell proliferation, dif-
ferentiation, apoptosis, and inflammation 
(Haarmann-Stemmann et al. 2009). Most 
TCDD effects are mediated by its binding to 
the aryl hydrocarbon receptor (AhR), leading 
to AhR nuclear translocation, heterodimeriza-
tion with aryl hydrocarbon receptor nuclear 
translocator (ARNT), and binding to xeno-
biotic responsive elements present in the pro-
moters of target genes (Barouki et al. 2007; 
Puga et al. 2009). The mechanisms of action 
of other dioxins, furans, and certain PCBs 
such as PCB-126 are thought to be similar to 
those of TCDD, albeit with different poten-
cies (Denison et al. 2002). In contrast, the 
mechanisms of action of other PCBs such as 
PCB-153 are poorly understood.
Adipose tissue (AT) is particularly relevant 
for the assessment of POP effects. POPs are 
lipophilic compounds stored primarily in the 
fat mass, which accounts for their long half-life 
(approximately 10 years). Pharmacokinetic 
studies suggest that this is the case for TCDD, 
particularly at low environmentally relevant 
doses (Emond et al. 2006). Furthermore, 
kinetic studies indicate that fat mass is among 
the major determinants of POP apparent 
half-lives in humans (Milbrath et al. 2009). 
Although this storage function may be protec-
tive to a certain extent, it also leads to a chronic 
low-grade internal exposure of humans to these 
toxicants (Kim et al. 2010). Furthermore, 
AT has important endocrine and metabolic 
physiological functions and could itself be a 
privileged target of these pollutants. Metabolic 
diseases and obesity are accompanied by a 
major alteration of AT functions such as a state 
of chronic low-grade inflammation in which 
adipocytes and other AT cells (e.g., endothelial 
cells, immune cells, preadipocytes) play a role 
by producing inflammation-related media-
tors (Goldberg 2009). These inflammatory 
molecules contribute to marked perturbation 
of paracrine dialogues between those cells, 
which contributes to altered AT biology, pro-
moting, for example, local inflammation and 
metabolic alteration such as insulin resistance 
as well as increased remodeling and fibrosis 
(Dalmas et al. 2011). Stienstra et al. (2011) 
have suggested that the resulting deregulation 
in the secretion of some inflammatory media-
tors in the systemic circulation could contrib-
ute to numerous obesity comorbidities, such 
as cancers. Hence, it is critical to assess the 
effect of POPs on AT. Some studies reported 
antiadipogenic and pro  inflammatory effects of 
TCDD and the dioxin-like PCB-77 on mouse 
3T3-L1 cells (a mouse embryonic fibroblast 
cell line) (Arsenescu et al. 2008; Wen et al. 
2007) or mouse embryo fibroblasts (Alexander 
et al. 1998). TCDD was also found to impair 
insulin action, signaling, and secretion in insu-
lin-sensitive cells such as beta cells and adipo-
cytes (Hsu et al. 2010; Nishiumi et al. 2010; 
Piaggi et al. 2007). Limited studies have been 
devoted to human adipocytes.
Our aim was to evaluate the effects of 
AhR ligands on adipocyte functions. We first 
identified human multipotent adipose-derived 
stem (hMADS) cells as an appropriate model 
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Ba c k g r o u n d: Epidemiological studies emphasize the possible role of persistent organic pollutants 
(POPs) in obesity and the metabolic syndrome. These pollutants are stored in adipose tissue (AT).
oBjectives: Our aim was to study the effects of POPs on human adipose cells and rodent AT.
Me t h o d s : Using human multipotent adipose-derived stem cells, we carried out large-scale gene expres-
sion analysis to identify the major pathways modified by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 
polychlorinated biphenyl (PCB) congener 126 (PCB-126), and PCB-153 and to evaluate their toxic 
effects. The effects of TCDD on gene expression and AT histology were also assessed in mice.
re s u l t s: The most significantly regulated genes in both precursor cells and adipocytes were those 
involved in the inflammatory/immune response, cancer, and metabolism pathways. Interestingly, 
the fold induction and the number of modulated genes were higher in precursors than in adipo-
cytes, suggesting that the former could be more sensitive to the effect of pollutants. When cells were 
treated with combinations of pollutants, the effects of the AhR ligands TCDD and PCB-126 were 
dominant compared with those of the non-dioxin-like PCB-153. The effects of AhR ligands were 
reduced by the AhR antagonist α-naphthoflavone. The regulation of inflammatory pathway was 
observed in wild-type AT but not in AhR-knockout mice.
co n c l u s i o n s: Both in vitro and in vivo studies showed that adipose cells were targets of AhR 
ligands and suggest that inflammation is one of the main regulated pathways. These observations 
suggest a possible contribution of pollutants to low-grade AT inflammation that accompanies the 
pathogenesis of metabolic diseases.
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to study the effect of pollutants on human 
adipocytes (Rodriguez et al. 2005a, 2005b; 
Zaragosi et al. 2006). We carried out large-
scale gene expression analyses to target the 
major pathways and genes that were altered by 
pollutants. We focused our studies on TCDD, 
PCB-126 (the most potent of the dioxin-like 
PCBs), and PCB-153 (the most abundant of 
the non-dioxin-like PCBs). We studied the 
effects of these POPs on both precursor cells 
and mature adipocytes. We also characterized 
the effect of dioxin on AT in wild-type (WT) 
and AhR-knockout (KO) mice.
Materials and Methods
Cell culture. Cell culture media were pur-
chased from Invitrogen (Cergy-Pontoise, 
France), human fibroblast growth factor 2 
(hFGF2) from Peprotech (London, UK), and 
all the other products from Sigma-Aldrich 
(Saint Quentin Fallavier, France).
The establishment and characterization 
of hMADS cells have been described previ-
ously (Rodriguez et al. 2005a). Proliferating 
cells were seeded in Dulbecco’s modified 
Eagle’s medium (DMEM) with 10% fetal calf 
serum, 2.5 ng/mL hFGF2, 10 mM HEPES 
buffer, 50 U/mL penicillin, and 50 μg/mL 
streptomycin and kept at 37°C in 5% CO2. 
hFGF2 was removed when cells reached con-
fluence. The next day, cells were incubated 
in differentiation medium: DMEM/Ham’s 
F-12 medium containing 10 μg/mL transfer-
rin, 5 μg/mL insulin, 0.2 nM triiodothyro-
nine, 100 μM 3-isobutyl-1-methylxanthine 
(IBMX), 1 μM dexamethasone (DEX), and 
0.5 μg/mL rosiglitazone. At day 3, DEX and 
IBMX were omitted from the differential 
medium until day 10. Differentiation (i.e., 
neutral lipid accumulation) was assessed by 
Oil Red O staining as described elsewhere 
(Rodriguez et al. 2005a). The experiments 
were carried out between days 11 and 13 
while the cells were treated for 48 hr with 
25 nM TCDD, 1 μM PCB-126, or 10 μM 
PCB-153, all dissolved in dimethyl sulfoxide 
(DMSO). For the 48-hr treatment of precur-
sor cells, the proliferating cells were treated at 
confluence by the same compounds, at the 
same concentrations.
Animals.  Homozygotic  WT  mice 
(C57BL/6) were purchased from Charles 
River Laboratories (Arbresle, France), and the 
inactivation of the AhR gene was performed 
to produce AhR-KO mice as described else-
where (Fernandez-Salguero et al. 1995). Mice 
were maintained on a standard 12-hr light/
dark cycle with ad libitum access to standard 
chow and water. Seven- to 8-week-old male 
mice were treated with a single intraperitoneal 
injection of 10 μg/kg TCDD dissolved in corn 
oil (Sigma-Aldrich) or vehicle control (corn 
oil). At 48 hr or 72 hr after intraperitoneal 
injection, the mice were killed by asphyxiation 
with CO2. This dose of TCDD was selected 
because previous studies in rodents suggested 
that it led to AT concentrations that were 
within the range of those used in our in vitro 
studies (Wang et al. 2000). The animals were 
treated humanely and with regard for allevia-
tion of suffering.
Determination of mRNA Levels. Total 
RNA was extracted from undifferentiated 
or in vitro differentiated adipocytes with 
the RNeasy Total RNA Mini Kit (Qiagen, 
Courtaboeuf, France) and from mouse AT 
with RNeasy Lipid Tissue Mini Kit (Qiagen). 
Total RNA concentration was assessed spec-
trophotometrically with a NanoDrop spectro-
photometer (Thermo Scientific, Wilmington, 
DE, USA), and their quality was determined 
with the Agilent 2100 Bioanalyzer (Agilent 
Technologies, Massy, France). Total RNA 
(1 μg) was reverse transcribed using a high-
capacity cDNA reverse transcription kit 
(Applied Biosystems, Courtaboeuf, France). 
Real-time polymerase chain reactions (PCRs) 
were conducted with ABsolute™ QPCR 
SYBR® Green ROX mix (Thermo Electron 
SAS, Courtaboeuf, France) on an Applied 
Biosystems 7900HT Fast Real-Time PCR 
System (Applied Biosystems). mRNA values 
were normalized to the expression level of a ref-
erence gene. We tested hypoxanthine-guanine-
phosphoribosyltransferase (HPRT), TATA box 
binding protein (TBP), and ribosomal protein 
L13A. HPRT had the most stable expression 
level among different conditions in precursor 
cells and mouse AT, and TBP had the most 
stable expression level in adipocytes. Primer 
sequences are available upon request.
Immunohistochemistry. Epididymal 
AT biopsies were fixed overnight at 4°C in 
4% paraformaldehyde and then processed 
for standard paraffin embedding. Sections 
of 5 μm were stained as described below 
and observed under a Zeiss 20 Axiostar Plus 
microscope (Zeiss, Oberkochen, Germany). 
Digital images were captured by tri-CCD 
camera (DXC-390P; Sony, Paris, France).
Adipocyte diameter. Slides were stained 
with hematoxylin and eosin. Adipocyte diam-
eters were measured using PerfectImage soft-
ware, version 7.4 (Claravision, Massy, France). 
We estimated the diameter of all adjacent 
adipocytes from each of four separate pho-
tographs of the same slide in parenchyma. 
These measurements were performed at 10× 
magnification, with 200–300 adipocyte diam-
eters measured for each biopsy to calculate the 
mean and SE for each sample.
Macrophages accumulation. Anti-mouse 
F4/80 antibody (AbD Serotec, Düsseldorf, 
Germany) was used to detect macrophages 
(Khazen et al. 2005). Immunohistochemical 
detection was performed with the avidin–
biotin peroxidase method as described pre-
viously (Cancello et al. 2006). Slides were 
counterstained with Mayer’s hematoxylin. 
Adipocytes and F4/80-positive cells were 
counted in 10 different randomly chosen areas 
in each processed slide at 40× magnification. 
The number of F4/80 cells per 100 adipocytes 
was considered the number of infiltrating AT 
macrophages.
Cytokine measurements. Cytokine concen-
trations in supernatants of cultured undiffer-
entiated cells and adipocytes were determined 
by Luminex assay with a custom kit, Human 
Adipocyte Multiplex Immunoassay Kit  –FOUR 
PLEX (Millipore, Saint Quentin-en-Yvelines, 
France) according to the manufacturer’s pro-
tocols using the Luminex xMAP Multiplexing 
Technology platform (Hôpital Saint Antoine, 
Paris, France).
Sample preparation for microarray 
analyses. Total RNA (200 ng) from each 
sample (each condition in quadruplicate) 
was amplified and transcribed into fluores-
cent cRNA with the Low RNA Input Linear 
Amplification Kit (Agilent Technologies). 
Cyanine-5 dye was incorporated into the con-
trol (DMSO treated) sample, whereas samples 
treated with TCDD, PCB-126, or PCB-153 
were labeled with cyanine-3 dye. Samples 
were then hybridized to Agilent whole human 
genome microarrays (Whole Human Genome 
Microarray Kit, 4x44K). Sample preparation, 
hybridization, and microarray washing were 
performed according to the manufacturer’s 
recommendations. Arrays were scanned with 
a GenePix 4000B scanner (Axon Instruments-
Molecular Devices, Sunnyvale, CA, USA).
Statistical analysis. For all microarrays, 
after loess normalization of log-transformed 
microarray data with the use of the Goulphar 
package (version 1.1.3; http://transcriptome. 
ens.fr/goulphar/index.php) (Lemoine et al. 
2006), gene lists were filtered to iden-
tify genes common to all microarrays (i.e., 
100% retrieval). Differential gene expression, 
using a 5% false discovery rate, was assessed 
with the use of the Significance Analysis of 
Microarrays (SAM; version 3.02) procedure 
(http://www-stat.stanford.edu/~tibs/SAM/). 
The functional profiling of gene expression 
data was determined using FunNet (http://
www.funnet.info), which was described 
elsewhere (Prifti et al. 2008). The complete 
data set is publicly available at the National 
Center for Biotechnology Information Gene 
Expression Omnibus (http://www.ncbi.nlm.
nih.gov/geo/) through series accession number 
GSE32026 and is also available on request 
from the authors.
For quantitative reverse transcriptase (qRT) 
PCR gene expression and cytokine measure-
ments, Kruskal–Wallis and/or Mann–Whitney 
U-test using StatView 5.0 (SAS Institute Inc., 
Cary, NC, USA) was performed. Results are 
presented as the mean ± SE. p-Values < 0.05 
were considered significant.Kim et al.
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hMADS, a valuable human adipocyte model 
to evaluate pollutant toxicity. hMADS exhibit 
features of stem cells, that is, a high ability to 
self-renew and the capacity to differentiate 
into different lineages, including adipocytes 
[see Supplemental Material, Figure 1 (http://
dx.doi.org/10.1289/ehp.1104282)]. The differ-
entiated cells exhibit the unique characteristics 
of human adipocytes, unlike rodent preadi-
pocyte cell lines, for example, hMADS can 
secrete leptin and adiponectin. Furthermore, 
cytochrome P450 1B1 (CYP1B1), a consti-
tutively expressed CYP1 family member in 
extrahepatic tissues, is potently induced by 
TCDD in both precursor and differentiated 
cells [see Supplemental Material, Tables 1, 2 
(http://dx.doi.org/10.1289/ehp.1104282)]. 
AhR is also expressed in these cells. Thus, this 
cell line appears to be an adequate model for 
the assessment of the toxic effect of pollutants 
on human undifferentiated and differentiated 
adipocytes.
Large-scale studies and major gene regu-
lation by TCDD, PCB-126, or PCB-153. 
Preliminary studies allowed us to determine 
the amount of pollutants to be used in in vitro 
experiments. We chose the amount that 
resulted in a statistically significant induction 
of selected target genes without inducing cel-
lular toxicity [measured by the MTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl  tetrazolium 
bromide] assay; data not shown]. Gene expres-
sion was monitored by large-scale microar-
ray analysis comparing treated and untreated 
cells. The sets of genes differentially modulated 
by each pollutant were determined by SAM 
with a false discovery rate of 5%. In precur-
sor cells, the expression of 236, 1,344, and 
792 genes was up-regulated and that of 17, 
158, and 104 genes was down-regulated by 
TCDD, PCB-126, and PCB-153, respectively. 
In adipocytes, the expression of 477, 117, and 
441 genes was up-regulated and that of 153, 
13, and 399 genes was down-regulated by 
TCDD, PCB-126, and PCB-153, respectively 
(data not shown, available upon request). To 
identify the enrichment in functional groups 
in up- and down-regulated gene lists, we used 
the FunNet tool. According to KEGG (Kyoto 
Encyclopedia of Genes and Genomes; http://
www.genome.jp/kegg/) (Kanehisa and Goto 
2000; Kanehisa et al. 2011) pathways, the 
inflammatory response was strongly induced by 
all the pollutants in precursor cells. Chemokine 
signaling pathway, cytokine–cytokine recep-
tor interaction, and the JAK-STAT signaling 
pathway represented more than 50% of up-
regulated transcripts in TCDD-treated and 
PCB-126–treated cells (Figure 1A,B). Other 
pathways, such as cell adhesion, metabolism, 
and cancer pathways, were also modulated by 
all pollutants (Figure 1A–C).
Figure 1. Functional profiling of microarray data determined by FunNet. (A–C) Precursor hMADS cells treated with 25 nM TCDD (A), 1 μM PCB-126 (B), or 10 μM 
PCB-153 (C) for 48 hr. (D–F) Differentiated hMADS cells treated with 25 nM TCDD (D), 1 μM PCB-126 (E), or 10 μM PCB-153 (F) for 48 hr. Abbreviations: ECM, extra-
cellular matrix; mTOR, mammalian target of rapamycin; NOD, nucleotide-binding oligomerization domain; TGFβ, transforming growth factor-β.
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In adipocytes, results suggested that cancer-
related pathways were modulated by pollutants 
(Figure 1D–F); in particular, those involved in 
leukocyte transendothelial migration pathway 
were up-regulated by all three compounds. 
Because leukocyte migration from blood to 
tissues is important for the inflammatory 
response, this is in agreement with the 
increased inflammation observed in AT after 
pollutant treatment.
Determination of effects of pollutants by 
qRT-PCR. We first validated the micro  array 
observation by qRT-PCR by measuring the 
expression of genes involved in metabolism 
[CYP1B1, CYP19A1, fatty acid binding 
protein 4 (FABP4), NAD(P)H dehydroge-
nase, quinone 1 (NQO1)], cell adhesion or 
migration [intercellular adhesion molecule 1 
(ICAM1), transforming growth factor, 
beta-induced (TGFBI), thrombo  spondin 1 
(THBS1), vascular cell adhesion molecule 1 
(VCAM1)], inflammation [chemokine 
(C-X-C motif) ligand 12 (CXCL12), inter-
leukin 1β (IL1B), IL8, plasminogen activa-
tor inhibitor 2 (PAI2), signal transducer and 
activator of transcription 1 (STAT1), tumor 
necrosis factor receptor superfamily, member 
11b (TNFRSF11B)], and cancer pathways 
[insulin-like growth factor binding protein 3 
(IGFBP3), prostaglandin-endoperoxide syn-
thase 2 (PTGS2), tribbles homolog 3 (TRIB3), 
wingless-type MMTV integration site fam-
ily, member 5A (WNT5A)]. Both precursors 
and adipocytes were treated with TCDD, 
PCB-126, or PCB-153. Several mRNAs, such 
as those encoding CYP1B1, IL8, neuronal 
pentraxin 1 (NPTX1), PAI2, PTGS2, NQO1, 
STAT1, TGFBI, THBS1, TNFRSF11B, and 
WNT5A, were induced in both types of cells 
by the AhR ligands TCDD and PCB-126, 
and the fold induction of expression was gen-
erally higher in precursors than in adipo  cytes 
[see Supplemental Material, Tables 1 and 2 
(http://dx.doi.org/10.1289/ehp.1104282)]. 
The level of transcripts encoding CYP19A1, 
FABP4, ICAM1, IGFBP3, IL1B, TRIB3, or 
VCAM1 was modulated only in precursors. 
We also assessed the expression level of AHR 
mRNA because it was previously found to 
decrease during adipogenesis in 3T3-L1 cells, 
resulting in the loss of functional response to 
xeno  biotics (Shimba et al. 1998). In hMADS, 
AHR expression was similar at the two cell 
stages and was significantly decreased by the 
treatment with AhR ligand in precursors (see 
Supplemental Material, Table 1). Thus, the 
greater sensitivity of precursor cells did not 
seem to be related to AHR expression level.
PCB-153 modulated the expression of 
some of the selected genes in precursors but 
not in adipocytes [see Supplemental Material, 
Tables 1 and 2 (http://dx.doi.org/10.1289/
ehp.1104282)]. The effect of PCB-153 in 
precursors was similar to that of AhR ligands 
for CYP19A1, ICAM1, PTGS2, TNFRSF11B, 
and VCAM1 and different for CXCL12, 
IL1B, IGFBP3, NPTX1, STAT1, THBS1, 
and WNT5A. In adipocytes, no regulation 
was observed.
Pro- and anti-inflammatory effects of 
TCDD, PCB-126, and PCB-153. We further 
characterized the gene family of the inflam-
matory network by measuring the expression 
of additional pro- and anti-inflammatory 
genes involved in obesity-related low-grade 
inflammation in AT. We tested the regulation 
of the pro  inflammatory genes CD14, IL6, 
IL8, monocyte chemoattractant protein 1 
(MCP1), CCl2, PAI1, and tumor necrosis fac-
tor-alpha (TNFα) and the anti-inflammatory 
genes CD163, interleukin 1 receptor antago-
nist (IL1ra), and IL10, all reported to code 
for secreted proteins that are up-regulated in 
obesity (Fain 2010). In precursors and adipo-
cytes, TNFα and IL10 mRNA were undetect-
able. IL1ra and PAI1 mRNA were increased, 
whereas CD14 mRNA was decreased, by 
TCDD and PCB-153 only in precursors 
(Figure 2A). MCP1 and IL8 mRNAs were 
increased by AhR ligands in both types of cells 
(Figure 2A,B). Thus, AhR ligands regulated 
the expression of genes encoding pro- and 
anti-inflammatory cytokines involved in the 
regulation of obesity-associated inflammation. 
In contrast, the pattern of gene regulation by 
PCB-153 was different from that of the other 
POPs: it elicited a decrease in the expression 
of CD14, IL6, MCP1, and PAI1 genes and 
an increase in IL1ra only in precursor cells 
Figure 2. Regulation of cytokines involved in obesity-related inflammation. mRNA levels were assessed by qRT-PCR of commonly regulated pro- and anti-inflam-
matory cytokines in obesity-related low-grade inflammation in undifferentiated cells (A) and adipocytes (B) treated with a single concentration of TCDD (25 nM), 
PCB-126 (1 μM), or PCB-153 (10 μM). Gene expression was normalized by HPRT or TBP expression using the ΔΔCt method and is expressed as mean of fold 
induction ± SE. (C) Measurement of pro  inflammatory cytokine secretion by Luminex assay in the supernatants of undifferentiated cells or adipocytes treated with 
25 nM TCDD or 1 μM PCB-126 for 48 hr. Data are expressed as mean ± SE.
*p < 0.05, compared with control by Mann–Whitney U-test.
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(Figure 2A). Because of its modest effects, we 
did not further pursue the characterization of 
PCB-153 effects.
To evaluate whether gene expression cor-
relates with the corresponding proteins, we 
analyzed the secretion of IL1β, IL6, IL8, and 
MCP1 in supernatants of cultured precur-
sors and adipocytes (Figure 2C). The secre-
tion level of cytokines was higher in precursors 
than in adipocytes, and IL8 was significantly 
increased by a 48-hr treatment with TCDD 
or PCB-126. IL1β secretion was undetectable. 
IL6 and MCP1 secretion were not significantly 
changed by TCDD or PCB-126 treatment.
The involvement of AhR in the inflamma-
tory response was evaluated with an antago-
nist of TCDD, α-naphthoflavone (α-NF). 
The induction of CYP1B1, a prototypical 
AhR target gene and of pro  inflammatory 
genes by TCDD or PCB-126 were signifi-
cantly decreased when cells were pre  treated 
with α-NF (Table 1), suggesting that these 
xeno  biotics could regulate the inflammatory 
pathway in adipose cells via the AhR.
AhR-dependent regulation of inflammatory 
genes in mouse AT. Because of the importance 
of inflammation in the pathogenesis of obesity 
and metabolic disease, we   studied the effect of 
AhR ligands in vivo on the epi  didymal AT 
of WT and AhR-KO mice. C57BL/6 male 
mice were treated with 10 μg/kg TCDD, 
a nonacutely toxic dose (Chapman and 
Schiller 1985) used in other similar studies 
(Schlezinger et al. 2010), and the expression 
of pro  inflammatory (Figure 3A) and anti-
inflammatory (Figure 3B) markers was 
assessed. The expression of Cyp1b1 and Nqo1 
genes that are typical AhR targets was induced 
in AT of TCDD-treated WT mice. Gene 
expression of the proinflammatory cytokines 
Il1b and Ptgs2 and of the anti-inflammatory 
cytokine Il10 was also increased in TCDD-
treated animals. This modulation could not 
be observed in AhR-KO mice.
Because the local inflammation observed 
in the AT of obese subjects was generally 
correlated with the increased infiltration of 
macro  phages and leukocytes (Dalmas et al. 
2011), we examined mouse AT by immuno-
histology. Specific staining with F4/80 
antibody showed an increased number of 
macrophages in TCDD-treated animals 
(Figure 4A,B). Because adipocyte hypertrophy 
is a factor determining macrophage infiltra-
tion in AT (Weisberg et al. 2003), we assessed 
the relationship between adipocyte diameter 
in TCDD-treated and corn-oil–treated mice. 
We found no difference in adipocyte size 
between these two conditions (Figure 4C).
These in vivo data are in agreement with the 
results obtained using hMADS cells. Indeed, 
TCDD was able to regulate the expression of 
genes encoding pro- and anti-inflammatory 
cytokines via AhR and to increase macrophage 
infiltration in AT.
Discussion
Our results show that the hMADS cell line is 
a valuable model for the study of POP toxicity 
on human precursor and adipocytes because 
these cells respond to several pollutants at 
different differentiation stages. Observations 
made on these cells were confirmed in vivo by 
comparing AT from WT and AhR-KO mice. 
Some of our observations are in line with 
those made in human studies correlating POP 
levels with metabolic diseases (Airaksinen 
et al. 2011; Ha et al. 2007; Uemura et al. 
2009). However, although the dioxin doses 
we used are common and non  acutely toxic, 
this exposure regimen is different from that of 
humans who are continuously exposed to very 
low levels of contaminants. Thus, although 
our functional data appear to have relevance 
to human observations, the difference in 
exposure should be kept in mind.
A nonsupervised analysis of the micro  array 
data after treatment of precursors and adi-
pocytes with POPs showed that transcripts 
for proteins involved in inflammation were 
among the most robustly regulated. To vali-
date this results, we assessed the modulation of 
ICAM1 (Brake et al. 2006), NQO1 (Palming 
Table 1. Role of AhR in pro- and anti-inflammatory gene regulation in hMADS precursors and adipocytes: 
fold induction after treatment (mean ± SE).
Gene DMSO α-NF TCDD TCDD + α-NF PCB-126 PCB-126 + α-NF
Precursor cells
CYP1B1 1.01 ± 0.10 2.01 ± 0.21 9.29 ± 1.42 3.70 ± 0.65* 9.67 ± 1.61 4.61 ± 0.97*
IL1B 1.04 ± 0.18 1.84 ± 0.24 11.09 ± 1.11 3.04 ± 0.36* 8.93 ± 1.15 3.14 ± 0.27*
IL8 1.04 ± 0.21 1.64 ± 0.33 4.10 ± 0.82 1.93 ± 0.38* 4.18 ± 1.29 2.09 ± 0.13*
MCP1 1.01 ± 0.09 1.16 ± 0.14 2.62 ± 0.13 1.32 ± 0.21* 2.53 ± 0.12 1.33 ± 0.24*
PAI2 1.03 ± 0.17 2.01 ± 0.39 21.18 ± 4.40 2.92 ± 0.45* 14.98 ± 3.77 4.29 ± 0.78*
PTGS2 1.00 ± 0.03 1.43 ± 0.07 6.75 ± 1.29 2.29 ± 0.10* 5.78 ± 0.24 2.69 ± 0.31*
IL1ra 0.97 ± 0.29 1.54 ± 0.18 2.58 ± 0.66 1.01 ± 0.04* 2.21 ± 0.25 1.26 ± 0.13*
Adipocytes
CYP1B1 1.03 ± 0.17 0.72 ± 0.09 7.16 ± 1.67 1.89 ± 0.11* 6.94 ± 1.46 2.70 ± 0.60*
IL1B 1.04 ± 0.20 0.93 ± 0.07 1.00 ± 0.19 1.21 ± 0.18 1.31 ± 0.27 1.28 ± 0.16
IL8 1.02 ± 0.14 0.81 ± 0.16 1.81 ± 0.20 0.93 ± 0.11* 2.26 ± 0.96 1.25 ± 0.29
MCP1 1.07 ± 0.29 0.92 ± 0.07 1.88 ± 0.26 1.12 ± 0.16* 1.57 ± 0.32 1.16 ± 0.16
PAI2 1.01 ± 0.09 0.55 ± 0.16 3.93 ± 0.44 1.64 ± 0.33* 4.83 ± 0.52 2.30 ± 0.66*
PTGS2 1.03 ± 0.19 0.84 ± 0.10 1.63 ± 0.38 1.00 ± 0.12 2.07 ± 0.30 1.14 ± 0.02*
IL1ra 1.00 ± 0.05 1.09 ± 0.25 0.96 ± 0.00 1.23 ± 0.12 1.14 ± 0.01 1.35 ± 0.31
Gene expression was normalized by HPRT expression in undifferentiated cells and by TBP expression in adipocytes. 
*p < 0.05, For TCDD-treated or PCB-126–treated cells without versus with pretreatment with α-NF, by Mann–Whitney 
U-test.
Figure 3. Modulation of inflammatory pathway genes in mouse AT. We evaluated the modulation of expression of pro  inflammatory (A) or anti-inflammatory (B) 
markers by qRT-PCR using the ΔΔCt method by reporting the differences between Ct of the target gene of TCDD-treated mice and the mean Ct of corn-oil–treated 
mice and by using Hprt gene expression as the reference in the epididymal AT of AhR WT or KO mice treated with 10 μg TCDD/kg or corn oil and sacrificed 48 hr 
later. Data are expressed as mean ± SE. For each gene, data were statistically compared by the Kruskal–Wallis test, and if significant differences were found, the 
Mann–Whitney U-test was applied. Rantes, Regulated upon Activation, Normal T-cell Expressed, and Secreted; also known as CCL5.
*p < 0.05 compared with corn-oil–treated animals.
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et al. 2007), IGFBP3 (Chan et al. 2005), and 
THBS1 (Varma et al. 2008) by POPs because, 
in addition to their role in cell adhesion, xeno-
biotic metabolism, angiogenesis, and cancer, 
these genes were reported to be related to adi-
posity, insulin resistance, and inflammation. 
We showed that AhR ligands were able to 
up-regulate the expression of these aforemen-
tioned genes. These data are in agreement with 
the in vivo metabolic disruption associated 
with dioxin-like POP and other POP levels 
(Airaksinen et al. 2011; Uemura et al. 2009) 
and may partly explain the growing evidence 
on the relationship between obesity and can-
cer (Harvey et al. 2011). Such associations 
could be also explained by insulin signaling 
impairment (Hsu et al. 2010; Nishiumi et al. 
2010; Stienstra et al. 2011). However, the 
regulation of metabolic pathways appeared to 
be less prominent than that of the inflamma-
tory pathway in our studies.
Obesity-associated inflammatory genes 
such as IL1B, IL1ra, IL8, and PTGS2 
(Goldberg 2009; Stienstra et al. 2011) were 
also increased by AhR ligands in hMADS 
cells. These results are in agreement with a 
recent study conducted on in vitro differenti-
ated adipocytes from human bone marrow 
cells (Arsenescu et al. 2008; Li et al. 2008). 
We also showed that TCDD and PCB-126 
gene regulation was mediated by AhR 
because it was potently inhibited by the AhR 
antagonist α-NF. In AT of TCDD-treated 
mice, we observed a similar up-regulation of 
transcripts for several inflammatory medi-
ators (Il1b, Il10, Ptgs2) only in WT mice. 
Thus, our study suggests that the inflamma-
tory pathway could be induced by TCDD via 
AhR. The modulation of gene expression was 
accompanied by an increased infiltration of 
macrophages and confirmed the existence of 
a TCDD-induced inflammatory state of AT. 
In animal models of obesity, a relationship 
was shown between adipose cell size and the 
concentration of macrophages in the stroma 
vascular fraction of AT (Weisberg et al. 
2003). Such results were not found in the 
present study, suggesting that fat cell hyper-
trophy was not the sole determinant of mac-
rophage recruitment into AT. Interestingly, 
a recent study found an association between 
small adipose cells and inflammation in 
moderately obese, weight-stable individuals 
(McLaughlin et al. 2010), suggesting that the 
association between adipocyte diameter and 
inflammation is more complex.
An important point revealed by our stud-
ies is that precursor cells appeared to be more 
sensitive than adipocytes to certain effects 
of AhR ligands. These data are in agreement 
with Fain (2010), who compared the release 
and expression of adipokines by non  fat versus 
fat cells and showed that the non  fat cells, con-
taining adipose precursors, were more inflam-
matory than were fat cells. Several possible 
mechanisms could account for such observa-
tions. It is possible that adipocytes are less 
sensitive to AhR ligands because of their lipid 
compartment, which could divert these pol-
lutants from their protein targets. Although 
we cannot exclude this possibility, it seems 
unlikely because the induction of CYP1B1, 
a prototypical AhR target gene, appears to 
be similar at both cell differentiation stages. 
Alternatively, there may be stage specificity of 
AHR transcriptional effects, highlighting the 
relevance of precursor cells in the mechanisms 
of pollutant-elicited AT toxicity.
PCB-153 is a non-AhR ligand that was 
shown to display some toxicity in other sys-
tems, notably as a cancer promoter (Knerr 
and Schrenk 2006), but the genomic bio-
markers of PCB-153 exposure are not well 
identified. In hMADS, this pollutant dis-
played a moderate effect on differentiated 
cells. Interestingly, in undifferentiated cells, 
genes involved in cancer/inflammatory path-
ways such as CXCL12, IGFBP3, IL1B, and 
WNT5A were down-  regulated by PCB-153, 
whereas they were up-  regulated by AhR 
ligands. These observations highlight the criti-
cal role of AhR ligands in the modulation of 
inflammatory cytokines in adipocytes.
In conclusion, both our in vitro and in vivo 
studies suggest that adipocytes and their pre-
cursors are targets of POPs and that one of the 
main pathways that these pollutants trigger is 
inflammation. In view of the importance of 
this pathway in the pathogenicity of metabolic 
diseases, these observations indicate a possible 
mechanism of pollutant contribution to the 
development of these diseases.
Figure 4. Immunohistochemistry of mouse AT. (A and B) The staining of infiltrated macrophages with F4/80 antibody was quantified by considering the number 
of macrophages (arrows) per 100 adipocytes. (C) Adipocyte diameter (μm) was determined by measuring 200–300 adipocytes in four different fields of the same 
slide. Data are mean + SE. Ctrl, control.
*p < 0.05, Wilcoxon rank sum test between TCDD-treated and corn-oil–treated mice.
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